» Articles » PMID: 22993656

Findings of Multidimensional Instruments for Determining Psychopathology in Diabetic and Non-diabetic Hemodialysis Patients

Overview
Specialty General Medicine
Date 2012 Sep 21
PMID 22993656
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The aim of this study was to expand the research on psychiatric complications of end-stage renal disease (ESRD), as well as to examine the prevalence of a broad range of psychopathology in diabetic and non-diabetic hemodialysis (HD) patients.

Methods: One hundred nineteen HD patients were invited to enter the cross-sectional study. To assess quality of life, quality of sleep, mental status and depression and anxiety symptoms, the 36-item Short Form, Pittsburgh Sleep Quality Index (PSQI), Mini-Mental State Examination and Hospital Anxiety and Depression Scale, respectively, were used.

Results: The mean age of all patients was 56.9±16.1 years; 54 (45.4%) were female. In the diabetic patients group, 84.8% of the patients had low MCS scores, and 89.2% patients had low PCS scores; 73.9% were poor sleepers; 63.0% had cognitive decline; 62.0% patients were depressive symptoms; and 28.3%had symptoms of anxiety. When comparing the diabetic and non-diabetic patients, the diabetic patients had lower role-emotional, sleep duration, and sleep efficiency scores.

Conclusions: Incorporating a standard assessment and, eventually, treatment of psychopathologic symptoms into the care provided to diabetic and hemodialysis patients might improve quality of life and sleep, depressive symptoms and, reduce mortality risk.

Citing Articles

Residual kidney function and sleep quality in hemodialysis patients.

Ramezanzade E, Khosravi M, Jafarinezhad A, Sadeghi Dehbane S, Attarchi M Caspian J Intern Med. 2024; 15(4):682-689.

PMID: 39359454 PMC: 11444097. DOI: 10.22088/cjim.15.4.682.


Economic burden and cost-utility analysis of three renal replacement therapies in ESRD patients from Yunnan Province, China.

Wu H, Li Q, Cai Y, Zhang J, Cui W, Zhou Z Int Urol Nephrol. 2020; 52(3):573-579.

PMID: 32009220 DOI: 10.1007/s11255-020-02394-1.


Prevalence of Insomnia (Symptoms) in T2D and Association With Metabolic Parameters and Glycemic Control: Meta-Analysis.

Koopman A, Beulens J, Dijkstra T, Pouwer F, Bremmer M, van Straten A J Clin Endocrinol Metab. 2019; 105(3).

PMID: 31603475 PMC: 7110921. DOI: 10.1210/clinem/dgz065.


The effects and potential mechanisms of folic acid on cognitive function: a comprehensive review.

Enderami A, Zarghami M, Darvishi-Khezri H Neurol Sci. 2018; 39(10):1667-1675.

PMID: 29936555 DOI: 10.1007/s10072-018-3473-4.


What to eat for a better sleep in haemodialysis patients: Potential role of B vitamins intake and appetite.

Ongan D, Yuksel A Pak J Med Sci. 2017; 33(2):417-424.

PMID: 28523048 PMC: 5432715. DOI: 10.12669/pjms.332.11838.


References
1.
Johnson S, Dwyer A . Patient perceived barriers to treatment of depression and anxiety in hemodialysis patients. Clin Nephrol. 2008; 69(3):201-6. DOI: 10.5414/cnp69201. View

2.
Elder S, Pisoni R, Akizawa T, Fissell R, Andreucci V, Fukuhara S . Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2007; 23(3):998-1004. DOI: 10.1093/ndt/gfm630. View

3.
Sabry A, Abo-Zenah H, Wafa E, Mahmoud K, El-Dahshan K, Hassan A . Sleep disorders in hemodialysis patients. Saudi J Kidney Dis Transpl. 2010; 21(2):300-5. View

4.
Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View

5.
Covic A, Seica A, Gusbeth-Tatomir P, Gavrilovici O, Goldsmith D . Illness representations and quality of life scores in haemodialysis patients. Nephrol Dial Transplant. 2004; 19(8):2078-83. DOI: 10.1093/ndt/gfh254. View